Is DiaMedica Therapeutics Inc. overvalued?

DiaMedica Therapeutics Inc. (DMAC) — key valuation metrics and fundamentals.

No verdict

Price

$8.32

Fair value

—

Current P/E

—

Normal P/E

—

Market cap

$448.3M

Dividend yield

0.0%

Return on equity

-77.7%

Sector

Healthcare

Fair value compares DMAC's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 24 Sep 2026.

Related stocks